The usefulness of non-human primates in central nervous system safety pharmacology

被引:11
|
作者
Porsolt, Roger D. [1 ]
机构
[1] Porsolt SAS, ZA Glatigne, F-53940 Le Genest St Isle, France
关键词
Biting; Cognition; Delayed matching/non-matching-to-sample; Dystonia Executive function; Extrapyramidal symptoms (EPS); Frustration-aggression; Methods Non-human primates (NHP); Object retrieval; INTRAVENOUS PHARMACOKINETIC PARAMETERS; QUALITATIVE EVALUATION; ALZHEIMERS-DISEASE; OBJECT RETRIEVAL; RHESUS-MONKEYS; ANIMAL-MODELS; DRUGS; RAT; EXTRAPOLATION; PERFORMANCE;
D O I
10.1016/j.vascn.2013.03.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The present paper will suggest, on the basis of experimental evidence, that several non-human primate (NHP) procedures can be uniquely useful and relevant for central nervous system (CNS) safety pharmacology purposes. Methods and results: Classical antipsychotics (e.g. haloperidol) but not atypical antipsychotics (e.g. clozapine), in contrast to rodents, induce behavioral signs in NHP which are clearly homologous to those observed in humans and thus have high translational value. Operant techniques (delayed matching/non-matching-to-sample) and non-operant techniques (object retrieval) can be used in NHP to assess the facilitating and impairing effects of drugs on cognition. Brain structures sub-serving these functions are closer to humans in NHP than in rodents suggesting that drug data from NHP translate better to humans. Biting into a rubber tube can be induced in squirrel monkeys by exposure to non-reinforcement (frustration). This model is close to human notions of frustration/aggression, and is ethically more acceptable than methods using shock or animal fighting. It could therefore serve as a model of drug-induced irritability with potentially high translational value. Conclusion: There are cogent scientific reasons for selecting NHP in CNS and other safety pharmacology areas. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [21] How to integrate safety pharmacology end-points during toxicological studies in non-human primates for biologics?
    Ficheux, Herve
    Froget, Guillaume
    Legrand, Jean-Jacques
    TOXICOLOGY LETTERS, 2009, 189 : S259 - S259
  • [22] Fairness in Non-human Primates?
    Braeuer, Juliane
    Hanus, Daniel
    SOCIAL JUSTICE RESEARCH, 2012, 25 (03) : 256 - 276
  • [23] Measles in non-human primates
    Dogadov, Dmitriy I.
    Kyuregyan, Karen K.
    Goncharenko, Alexandra M.
    Mikhailov, Mikhail I.
    JOURNAL OF MEDICAL PRIMATOLOGY, 2023, 52 (02) : 135 - 143
  • [24] Sparganosis in non-human primates
    Chai, D
    Farah, I
    Muchemi, G
    ONDERSTEPOORT JOURNAL OF VETERINARY RESEARCH, 1997, 64 (03) : 243 - 244
  • [25] COOPERATION IN NON-HUMAN PRIMATES
    SILK, JB
    CHENEY, DL
    SEYFARTH, RM
    INTERNATIONAL JOURNAL OF PRIMATOLOGY, 1987, 8 (05) : 464 - 464
  • [26] TUBERCULOSIS IN NON-HUMAN PRIMATES
    MULDER, JB
    VETERINARY MEDICINE & SMALL ANIMAL CLINICIAN, 1976, 71 (09): : 1286 - 1287
  • [27] COLOBOMAS IN NON-HUMAN PRIMATES
    SCHMIDT, RE
    FOLIA PRIMATOLOGICA, 1971, 14 (3-4) : 256 - &
  • [28] Fairness in Non-human Primates?
    Juliane Bräuer
    Daniel Hanus
    Social Justice Research, 2012, 25 : 256 - 276
  • [29] HUMAN CENTRAL NERVOUS-SYSTEM PHARMACOLOGY OF TIAZOFURIN
    GREEN, RM
    HUGENHOLTZ, H
    RICHARD, M
    DENNERY, J
    HOPKINS, H
    THIBAULT, M
    STEWART, DJ
    JOURNAL OF NEURO-ONCOLOGY, 1984, 2 (03) : 288 - 288
  • [30] A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates
    Sabnis, Staci
    Kumarasinghe, E. Sathyajith
    Salerno, Timothy
    Mihai, Cosmin
    Ketova, Tatiana
    Senn, Joseph J.
    Lynn, Andy
    Bulychev, Alex
    McFadyen, Iain
    Chan, Joyce
    Almarsson, Orn
    Stanton, Matthew G.
    Benenato, Kerry E.
    MOLECULAR THERAPY, 2018, 26 (06) : 1509 - 1519